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Abstract
Introduction
Studies on Mean Platelet Volume (MPV) in children with Sleep Disordered Breathing (SDB)
report conflicting results and the hypothesis of an intermittent hypoxemia leading to a sys-
temic inflammation is reaching consensus. Vitamin D exerts anti-inflammatory properties
and its deficiency has been supposed to play a role in sleep disorders. Emerging interest is
rising about Primary Snoring (PS) since it is reasonable that also undetectable alteration of
hypoxia might predispose to an increased production of inflammatory mediators. In this per-
spective, in a group of children affected by SDB, our aim was to investigate MPV, vitamin D
and C Reactive Protein (CRP) levels, which had been previously evaluated separately in
different studies focused only on Obstructive Sleep Apnea Syndrome (OSAS).
Materials and Methods
We enrolled 137 children: 70 healthy controls (HC), 67 affected by SDB undergoing a poly-
somnographic evaluation, 22 with a diagnosis of PS and 45 with a diagnosis of OSAS. All
patients underwent routine biochemical evaluations including blood cell counts, CRP and
vitamin D.
Results
Children affected by SDB had a mean age of 8.49±2.19 and were prevalently males (23
females, 34%; 44 males, 66%). MPV levels were higher in OSAS and PS when compared
to HC; platelet count (PLT) and CRP levels were higher while Vitamin D levels were lower in
children with SDB when compared to HC. MPV levels were correlated with PLT (r = -0.54;
p<0.001), vitamin D (r = -0.39; p<0.001) and CRP (r = 0.21; p<0.01). A multiple regression
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was run to predict MPV levels from vitamin D, CRP and PLT and these variables signifi-
cantly predicted MPV (F = 17.42, p<0.0001; adjusted R2 = 0.37). Only platelet count and
vitamin D added statistically significantly to the prediction (p<0.05).
Conclusion
The present study provides evidence of higher MPV and lower vitamin D levels in children
with PS as well as in children with OSAS, and supports the underlying inflammation, hence,
highlighting the importance of an early diagnosis of this previously considered benign form
of SDB.
Introduction
Sleep disordered breathing (SDB) is very common in children [1–3] and includes diseases
ranging from Primary Snoring (PS) to Obstructive Sleep Apnea Syndrome (OSAS).[4] Chil-
dren affected by OSAS have intermittent episodes of complete or partial obstruction leading to
intermittent desaturations and/or arousals, and this condition of intermittent hypoxemia (IH)
and reoxygenation damages the endothelium,[5] determining significant changes in the cardio-
vascular system.[6] Platelet size, measured by Mean Platelet Volume (MPV), is a potential
marker of platelet reactivity since larger platelets are metabolically and enzymatically more
active showing a greater protrombotic potential.[7] In this perspective, it may be regarded as a
potentially useful biomarker of platelet activity in the setting of cardiovascular disease.[8] Of
note, platelet activation plays a fundamental role in the pathophysiology of thrombosis and
other inflammatory diseases, and MPV is influenced by thrombopoietin and numerous inflam-
matory cytokines regulating thrombopoiesis, hence it is a reflection of both proinflammatory
and prothrombotic conditions.[9]
The association between increasing MPV and disease severity has been demonstrated in
adults [10] and has been the object of many studies in children with OSAS. One recent study
highlighted that MPV is higher in patients with severe obstructive sleep apnea than in healthy
patients [11] and Sagit et al.[12] showed that MPV is increased in patients with septal deviation
and snoring due to severe upper aiway obstruction. In this complex relation beetween SDB and
MPV, SDB-related hypoxemia and/or sleep fragmentation may lead to a systemic inflamma-
tion as supported by the higher C reactive protein (CRP) levels in children with SDB,[13] in
particular when a neurocognitive dysfunction has developed.[14] In this perspective, another
potential interesting factor might be represented by vitamin D which may control the release of
proinflammatory cytokines and its deficiency has been associated with higher CRP [15] and
MPV.[16]
Although, in subjects affected by PS, OSAS cannot be diagnosed according to international
polysomnographic parameters, it is reasonable that also mild episodes of IH might predispose
to cell stress and determine an increased production of inflammatory mediators. In this per-
spective, current assessment techniques might not be sensitive enough to detect subtle gas
exchange abnormalities or sleep disturbance in this setting,[17] since many studies demon-
strated that children with PS, just like patients affected by OSAS, have cognitive and behavioral
morbidity, increased blood pressure and reduced arterial distensibility.[18,19] Recently, our
research group have demonstrated that children with PS have significantly higher levels of
resistin compared to control group,[20] and that NOX2-derived oxidative stress is involved in
artery dysfunction in SDB children, including both PS and OSAS.[21]
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In this perspective, our aim was to investigate, also in children with PS, MPV, vitamin D
and CRP levels which had been previously evaluated separately in different studies focused
only on OSAS.
Materials and Methods
We enrolled 67 consecutive SDB children and 70 healthy controls (HC) recruited between Feb-
ruary 2014 and June 2015 at the Pediatrics Department of “Sapienza” University of Rome. We
performed, on each subject, a complete physical examination, a full medical history, polysom-
nography and venous blood sampling. Snoring was investigated by a validated SDB question-
naire including questions about snoring frequency per week.[22,23] SDB children were divided
in PS (n = 45) and OSA (n = 22). PS was defined as snoring without apnea, sleep abnormalities
or gas exchange abnormalities.[24] According to the recent guidelines,[24] OSA is a breathing
disorder characterized by prolonged partial upper airway obstruction and/or intermittent com-
plete obstruction during sleep, with loss of normal ventilation during sleep and normal sleep
patterns. HC were consecutively selected during a routine health check-up and they did not
report symptoms of habitual snoring and/or rhinitis.
Exclusion criteria were as follows: presence of epilepsy, acute or chronic cardio-respiratory
diseases, neuromuscular diseases, acute or chronic inflammatory diseases, liver disease, serious
kidney disorders, overweight.
The study was approved by the Ethical Committee of “Sapienza University of Rome” and
written parental informed consent was obtained.
Adenoids and tonsils
Nasal Fibroptic Endoscopy was executed by an expert otorhinolaryngologist using a 2.7 mm
diameter endoscope. Adenoids dimensions were graded using criteria previously described by
Cassano et al.[25]: grade 1 for adenoids occluding more than 25% of the choanal opening,
grade 2 for adenoid tissue limited to the upper half (<50%), grade 3 for adenoid tissue extend-
ing over the rhinopharynx (<75%) with obstruction of choanal opening and partial closure of
tube ostium, grade 4 for almost total obstruction. Moreover, tonsillar hypertrophy was classi-
fied as 1 when tonsils were observed in the tonsillar pillar, 2 when they protruded out of the
tonsillar pillar, 3 when they reached the space between anterior tonsillar pillar and uvula, 4
when they attached to the uvula.[26]
Polysomnography
Standard overnight polysomnography recordings were performed by a Grass Heritage poly-
graph as previously described.[2] The following variables were recorded: body position and
oxygen saturation, thoracic and abdominal respiratory effort, six electroencephalogram chan-
nels, right and left electrooculogram, electromyogram of left and right tibialis anterior muscles,
chin electromyogram, electrocardiogram nasal flow.[2] Obstructive apnea was defined as
absence of airflow with constant respiratory effort for more than two baseline breaths, indepen-
dently of arterial oxygen saturation changes.[2] Hypopnea was defined as a reduction of at
least 50% but not more than 90% in the amplitude of the airflow signal and it was only quanti-
fied if longer than two baseline breaths and associated with arousals and/or an oxygen desa-
turations>3%.[27] The obstructive apnea-hypopnea index (OAHI) was defined as the total
number of apneic and hypopneic episodes per hour of sleep.[27] PS was diagnosed when
OAHI was<1 and SpO2 nadir90%; OSA was diagnosed if OAHI was1.[28,29]
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Blood sampling
Blood sampling was collected between 8.00 and 9.00 a.m. for routine biochemical evaluations,
including blood cells count, CRP and vitamin D. The serum level of 25-(OH)-vitamin D were
measured using a chemoluminescent immunoassay on a Liaison automatic analyzer (Liaison
25 OH Vitamin D TOTAL Assay, DiaSorin, Saluggia (VC), Italy). Data were expressed as
nanograms per milliliter. CRP was evaluated by latex immunoturbid assay (normal value 100–
6000 μg/L).
Statistic Analysis
Statistical analyses were performed using SPSS (Statistical Package of Social Sciences, Chicago,
IL, USA) software version 23. Descriptive statistics were performed expressing continuous data
as means with SDs and categorical data were expressed by frequency and percentage. Compari-
sons were evaluated using a t-test, ANOVA test and a chi-square test after assessing normality
with the Kolmogorov-Smirnov test. Linear regression analysis was performed to determine the
presence of an independent relationship between MPV, vitamin D, PLT and CRP. Moreover
an ordinal logistic regression is used to predict the severity of sleep disordered breathing (con-
sidering 0 as HC, 1 as PS and 2 as OSAS) given MPV, vitamin D, PLT and CRP. The relation-
ship between these variables was analyzed using Pearson’s correlation. A p-value less than 0.05
was considered statistically significant.
Results
Children affected by SDB had a mean age of 8.49+2.19 and were prevalently males (23 females,
34%; 44 males, 66%). Descriptive statistics of the samples of PS, OSA and HC is shown in
Table 1.
MPV was lower in OSAS and PS subjects when compared to HC, although this difference
was not significant when comparing specifically OSAS and PS; PLT and CRP levels were higher
while vitamin D levels were lower in children with SDB when compared to HC (Table 1 and
Fig 1). MPV was correlated with PLT (r = -0.54; p<0.001), vitamin D (r = -0.39, p<0.001),
Table 1. Descriptive statistics data.
HC PS OSAS p value
Number 70 45 22 /
Age (years) 9.04±3.91 9.00±1.75 7.62±3.09 ns
Females 30 (43%) 16 (35%) 7 (32%) ns
Males 40 (57%) 29 (65%) 15 (68%) ns
Adenoid hypertrophy / 26 18 ns
Tonsillar hypertrophy / 28 20 ns
BMI 17.56±4.8 18.29±3.60 16.78±.40 ns
MPV (fL) 7.57±0.56 8.09±0.94 8.48±0.93 <0.001
PLT (x109/L) 305.03±87.29 291.06±70.59 242.68±54.17 0.01
CRP (μg/L) 812.31±456.38 2102.44±5320.08 3242.11±6197.25 0.03
Vitamin D (ng/mL) 34.07±11.11 26.21±10.7 20.80±7.57 <0.001
Mean SpO2 / 97.3±1.4 90.4±19.6 0.006
AHI / 0.4±0.2 6.5±2.1 <0.001
HC, Healthy Controls; PS, Primary Snoring; OSAS, Obstructive Sleep Apnea Syndrome; BMI, Body Mass Index; MPV, Mean Platelet Volume; PLT,
Platelet count; CRP, C Reactive Protein; AHI, Apnea-hypopnea index.
doi:10.1371/journal.pone.0152497.t001
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CRP (r = 0.21; p<0.01), SpO2 (r = -0.23; p<0.05) and AHI (r = 0.29; p = 0.009). Moreover vita-
min D was related with AHI (r = -0.27; p0.01) while vitamin D levels, age and CRP were not
significantly related.
A multiple regression was run to predict MPV levels from vitamin D, CRP and PLT. The
assumptions of linearity, independence of errors, homoscedasticity, unusual points and nor-
mality of residuals were met. These variables statistically significantly predicted MPV,
F = 17.42, p<0.0001, adjusted R2 = 0.37. Only platelet count and vitamin D added statistically
significantly to the prediction, p<0.05. Regression coefficients and standard errors can be
found in Table 2.
Fig 1. Platelet number, Mean Platelet Volume, C Reactive Protein, and Vitamin D levels in Healthy Controls, primary Snoring and Obstructive Sleep
Apnea Syndrome children. (A) Platelet number (x109/L); (B) MPV(fL), Mean Platelet Volume; (C) CRP (μg/L), C Reactive Protein; (D) vitamin D (ng/ml);
HC, Healthy Controls; PS, Primary Snoring children; OSAS, Obstructive Sleep Apnea Syndrome children. P values were calculated with Anova and a post
hoc Bonferroni test.
doi:10.1371/journal.pone.0152497.g001
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In children with PS and OSAS another multiple regression was performed to further investi-
gate the effect of SpO2 and AHI on MPV, Vitamin D and PCR and the only significant model
showed as independent predictive variable associated with MPV, AHI (SE = 0.37; B = 0.25;
p<0.05) with R2 = 0.11.
Moreover the ordinal logistic regression showed an increase in vitamin D and platelet count
is associated with a decrease in the odds of having a more severe form of SDB, hence OSAS
instead of PS, with an odds ratio of 0.941 (95% CI 0.902, 0.981) Wald χ2 = 8.069, p<0.0005 and
0.992 (95% CI 0.985, 0.999) Wald χ2 = 4.984 p<0.05 respectively.
MPV, PLT, Vitamin D and CRP values were comparable between children with adeno-ton-
sillar and without adenoid or tonsillar hypertrophy (data not shown).
Discussion
The spectrum of SDB is characterized by persistent upper respiratory tract resistance leading to
hypoxia, with activation of the sympathetic nervous system and endothelial dysfunction.[24]
PS is currently viewed as the minimum anchor point of this spectrum, even though, despite the
absence of detectable intermittent hypoxia or repeated arousal, children with PS (70% of chil-
dren with SDB) experience similar cognitive and behavioral deficits and develop similar oxida-
tive stress mediators compared to children with OSA [21,22,24]
In our sample, we found higher MPV in children with SDB and a correlation between MPV
and PLT. Although this result is in line with previously published studies,[11] results in chil-
dren are often conflicting: while in 2013 Cengiz et al.[17] concluded that children with OSAS
caused by chronic tonsillitis and adenoid hypertrophy is associated with low MPV values, in
2014 Onder et al.[18] found no significant relation between MPV and obstructive adenoid
hypertrophy while recently Soyaliç et al.[19] reported higher MPV in children with obstructive
adenotonsillar hypertrophy when compared to healthy children. The inverse correlation
between MPV and PLT has been described as tendency to maintain hemostasis by preserving a
constant platelet mass.[30] Another interesting point is that AHI resulted an independent pre-
dictive variable associated with MPV. Similar findings were already argued by Varol et al. in
2010 in adults with OSA [31]. Inflammatory process, underlying SDB,[13] may influence
thrombopoiesis regulation and, hence, be the origin of decreased platelet volume.[30] The role
of MPV as a marker of inflammation, disease activity and efficacy of antinflammatory treat-
ment in several chronic inflammatory disorders is well known, although, in different inflam-
matory conditions, the direction of its reported changes is often opposite. In this perspective,
potentially conflicting results may be explained by the evidence that the size of circulating
platelets is dependent on the intensity of systemic inflammation, which can be viewed as a dis-
tinctive factor for classifying conditions associated with large and small-sized circulating plate-
lets. High-grade inflammatory conditions (example inflammatory bowel syndrome,
Table 2. Multiple regression coefficients and standard errors.
Variable B SEB β
Vitamin D -0.14 0.006 -0.191 *
PLT -0.005 0.001 -0.483 *
CRP 0.00002 0.000 0.153
*p<0.05
B, unstandardized regression coefficient; SEB, Standard error of the coefficient; β,standardized coefficient;
PLT, Platelet count; CRP, C reactive protein.
doi:10.1371/journal.pone.0152497.t002
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rheumatoid arthritis or Familial Mediterranean Fever) are associated with circulation of pre-
dominantly small platelets, whereas the same disorders at remission and controlled by anti-
nflammatory drugs are associated with large circulating platelets.[9]
A novel aspect emerging from the present study is that MPV levels are comparable in chil-
dren with OSAS and with PS as shown in Fig 1. This result underlines the importance of con-
sidering Primary Snoring not only as a milder form of OSAS, but rather as a sleep disorder
with its own dignity and characteristics, where an undetectable form of hypoxia and many
potential factors other than oxygen desaturation might contribute to the inflammation under-
lying this condition. In this direction, our research group have recently shown, in PS children,
higher levels of serum isoprostanes, soluble NOX2 and lower FMD when compared to HC.[24]
A possible explanation for this is that primary snorers experience more microarousals (shorter
than 3 seconds and sufficient to reestablish airway patency), greater sleep fragmentation, and/
or more episodes of subthreshold oxygen desaturation compared with normal controls [32]
and that routine PSG might not detect all the alterations by peripheral arterial tonometry [33].
Moreover, although CRP levels did not add a specific singular significant contribution to MPV
prediction in the regression analysis, they were progressively higher from HC to OSAS. In 2004
Tauman et al.[13] reported increased CRP levels among children with SDB and a correlation
with OAHI, highlighting particularly prominent changes in children who were sleepy or pre-
sented neurobehavioral complaints. These authors hypothesized that, in children affected by
SDB, the magnitude of inflammatory responses may ultimately lead to cardiovascular, cogni-
tive, and behavioral morbidities. Also Gozal et al. in 2007 [14] reported higher CRP levels in
children with OSA developing neurocognitive deficits, and suggested inflammation elicited by
OSA as a major determinant of increased risk for neurocognitive dysfunction. Of note these
studies were performed on children with a AHI>1 and Abdelnaby Khalyfa in 2011 [34] could
not find any significant difference in CRP levels between children with PS and controls. Present
results confirm this finding, but, further investigate and report a significant trend in CRP from
HC to PS and OSAS. Moreover, results concerning the relation between MPV and CRP should
be analyzed considering that adiposity is one of the major determinant of CRP in children [35]
and in our sample overweight children were exclude and that a follow up of these children
would be interesting to assess the potential increase in CRP over time. Moreover, results should
be regarded in the light of the small sample size which may be identified as a limitation of the
present study and hence, they should be confirmed by further studies on larger sample of chil-
dren. Another potential limitation is the lack of polysomnographic data of healthy subjects
although these patients did not report any symptom to justify such an expensive and time con-
suming exam, especially in children.
Furthermore, in the present study, vitamin D levels were lower in PS and OSAS when com-
pared to HC and they were significantly related with MPV; the decrease in vitamin D levels is
associated with an increase in the odds of having OSAS instead of PS. The relationship between
vitamin D and inflammation is still controversial. [36] One of the main hypothesis is that
inflammation may lower 25(OH)D concentration via oxidative stress resulting in the oxidative
catabolism of 25(OH)D. [37] We speculate that the interference of an oxidative stress on
metabolizing enzymes responsible of liver’s biosynthesis of 25(OH)D and the evidence of oxi-
dative environment in children with PS (24) might be helpful to understand these results. In
2013 Mete et al.[38] showed that lower Vitamin D levels correspond to an increase of OSAS
severity independently from BMI values. Although the relation between sleep and vitamin D
levels is still controversial, many mechanisms may be implied: for example, TNF-alpha has a
role in the pathogenesis of sleep apnea syndrome and is negatively correlated with vitamin D,
[39] and the need for sleep during daytime may decrease exposure to sunlight.[40] On the
other hand, the relationship between Vitamin D and MPV found in the present study is in line
MPV, Vitamin D and CRP levels in Normal Weight Children with PS and OSAS
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with results shown by Cumhur Cure in 2014 [41] that showed that low vitamin D is indepen-
dently associated with a high MPV. Raid et al.[42] hypothesized an inverse correlation between
tonsils size and vitamin D, although this correlation was not statistically confirmed on multiple
linear regression analysis. In the present study, MPV, PLT, Vitamin D and CRP values were
comparable between children with adeno-tonsillar and without adenoid or tonsillar hypertro-
phy. Moreover, vitamin D levels were not related with CRP, partially in line with authors
reporting the association between vitamin D and CRP as potentially biased by confounding
factors.[43] In this sense the lack of an additional inflammatory marker other than CRP has to
be disclosed as a potential limit of this study.
Vitamin D deficiency exerts anticoagulant effects by upregulating the expression of an anti-
coagulant glycoprotein (thrombomodulin) and downregulating the expression of a critical
coagulation factor (tissue factor) in monocytes,[44] and increases itself the release of proin-
flammatory cytokines such as IL-6 and TNF-α [45] that may lead to a high MPV.[41] Conse-
quently, high MPV, but also vitamin D deficiency per se, increases cardiac disease risk. In
adults, Vitamin D deficiency is associated with an increase of cardiovascular diseases, in partic-
ular when 25-(OH)-vitamin D level is below 30 ng/mL.[46] Many mechanisms may be implied
in this link between vitamin D deficiency and cardiovascular disease, such as the participation
of 1,25-(OH)-vitamin D in the regulation of renin-angiotensin axis and in the modulation of
smooth muscle cell proliferation, as well as inflammation and thrombosis.
Conclusions
In conclusion, the present study provides the evidence of higher MPV and vitamin D defi-
ciency in children with PS, as well as in children with OSAS, and assess the potential role of an
underlying inflammation, hence, highlighting the importance of an early diagnosis of this pre-
viously considered benign form of SDB.
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